Chemistry:4-HO-McPT
From HandWiki
4-HO-McPT, also known as 4-hydroxy-N-methyl-N-cyclopropyltryptamine, is a psychedelic tryptamine derivative. It has serotonergic effects,[1] and has reportedly been sold as a designer drug since around 2016, but was not definitively identified by forensic laboratories until 2018.[2][3]
Contents
Interactions
Pharmacology
4-HO-McPT produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[4] It has been found to act as a serotonin reuptake inhibitor.[4]
Chemistry
Analogues
Analogues of 4-HO-McPT include methylcyclopropyltryptamine (McPT), N-cyclopropyltryptamine (NcPT), 4-AcO-McPT, 5-MeO-McPT, 4-HO-McPeT, 4-HO-MiPT, 4-HO-MALT, 4-HO-MiPT, 4-HO-MPT, and 4-HO-EPT, among others.
Society and culture
Legal status
Finland
4-HO-McPT is illegal in Finland.[5]
See also
References
- ↑ Chadeayne, Andrew R, "Compositions comprising a psilocybin derivative and a cannabinoid", US patent application 2019142851, published 2019-05-16, now abandoned.
- ↑ "PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra.". Blotter 3 (1). March 2018. doi:10.16889/isomerdesign-5.
- ↑ "Analytical Report: 4-HO-McPT.". Nacionalni Forenzični Laboratorij. Slovenia. September 2018. https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/4-HO-McPT-ID-1961-18_report.pdf.
- ↑ 4.0 4.1 "Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-N-methyl-N-isopropyltryptamine and Related Analogs". ACS Chem Neurosci. May 2026. doi:10.1021/acschemneuro.6c00083. PMID 42200433.
- ↑ Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista
External links
| DAT (DRIs) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NET (NRIs) |
| ||||||||||||||
| SERT (SRIs) |
| ||||||||||||||
| VMATs | |||||||||||||||
| Others |
| ||||||||||||||
|
0.00 ![]() ![]() ![]() ![]() (0 votes) |
